An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule

Tekijä Hörig, Heidi, Papadopoulos, Nicholas J., Vegh, Zsuzsanna, Palmieri, Edith, Angeletti, Ruth H., Nathenson, Stanley G.
Julkaistu 1997

T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell

Tekijä González, Pablo A., Carreño, Leandro J., Coombs, Daniel, Mora, Jorge E., Palmieri, Edith, Goldstein, Byron, Nathenson, Stanley G., Kalergis, Alexis M.
Julkaistu 2005

Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy

Tekijä Lázár-Molnár, Eszter, Scandiuzzi, Lisa, Basu, Indranil, Quinn, Thomas, Sylvestre, Eliezer, Palmieri, Edith, Ramagopal, Udupi A., Nathenson, Stanley G., Guha, Chandan, Almo, Steven C.
Julkaisussa EBioMedicine (2017)

Predominant occupation of the class I MHC molecule H-2K(wm7) with a single self-peptide suggests a mechanism for its diabetes-protective effect

Tekijä Brims, Daniel R., Qian, Jie, Jarchum, Irene, Mikesh, Leann, Palmieri, Edith, Ramagopal, Udupi A., Malashkevich, Vladimir N., Chaparro, Rodolfo J., Lund, Torben, Hattori, Masakazu, Shabanowitz, Jeffrey, Hunt, Donald F., Nathenson, Stanley G., Almo, Steven C., DiLorenzo, Teresa P.
Julkaistu 2010